UCB Pharma S.A.
- L04 - Inmunosupresores
- BIMZELX PREFILLED PEN solution for injection 160 mg/1 ml
- BIMZELX PREFILLED SYRINGE solution for injection 160 mg/1 ml
- CIMZIA PREFILLED SYRINGE solution for injection 200 mg/1 ml
- M05 - Preparados para el tratamiento de enfermedades óseas
- EVENITY PREFILLED SYRINGE solution for injection 105 mg/1.17 ml
- N03 - Antiepilépticos
- KEPPRA concentrate for solution for infusion 300 mg/3 ml
- KEPPRA concentrate for solution for infusion 500 mg/5 ml
- KEPPRA film-coated tablet 1 000 mg
- KEPPRA film-coated tablet 250 mg
- KEPPRA film-coated tablet 500 mg
- KEPPRA film-coated tablet 750 mg
- KEPPRA oral solution 100 mg/ml
- LACOSAMIDE UCB film-coated tablet 100 mg
- LACOSAMIDE UCB film-coated tablet 150 mg
- LACOSAMIDE UCB film-coated tablet 200 mg
- LACOSAMIDE UCB film-coated tablet 50 mg
- LACOSAMIDE UCB INIZIO TRAIT film-coated tablet 50 mg - 100 mg - 150 mg - 200 mg
- LACOSAMIDE UCB solution for infusion 10 mg/ml
- LACOSAMIDE UCB syrup 10 mg/ml
- NUBRIVEO film-coated tablet 10 mg
- NUBRIVEO film-coated tablet 100 mg
- NUBRIVEO film-coated tablet 25 mg
- NUBRIVEO film-coated tablet 50 mg
- NUBRIVEO film-coated tablet 75 mg
- NUBRIVEO oral solution 10 mg/ml
- NUBRIVEO solution for injection 10 mg/ml
- VIMPAT film-coated tablet 100 mg
- VIMPAT film-coated tablet 150 mg
- VIMPAT film-coated tablet 200 mg
- VIMPAT film-coated tablet 50 mg
- VIMPAT solution for infusion 10 mg/ml
- N04 - Antiparkinsonianos
- NEUPRO transdermal patch 1 mg/24 h
- NEUPRO transdermal patch 2 mg/24 h
- NEUPRO transdermal patch 2 mg/24 h - 4 mg/24 h - 6 mg/24 h - 8 mg/24 h
- NEUPRO transdermal patch 3 mg/24 h
- NEUPRO transdermal patch 4 mg/24 h
- NEUPRO transdermal patch 6 mg/24 h
- NEUPRO transdermal patch 8 mg/24 h